Seibu tablets are designed to address motion sickness, a common condition characterized by symptoms such as nausea, vomiting, and dizziness experienced during travel or motion. These tablets contain three active ingredients: scopolamine hydrobromide hydrate, chlorpheniramine maleate, and anhydrous caffeine.
The active ingredient scopolamine hydrobromide hydrate is known for its anticholinergic properties, which can help alleviate symptoms of motion sickness by reducing the signals sent to the brain that cause nausea and vomiting. Chlorpheniramine maleate, another active ingredient, possesses antihistamine properties that can counteract the inner ear disturbances contributing to motion sickness symptoms. Lastly, anhydrous caffeine is included, which may have a mild stimulating effect that can potentially help in reducing fatigue and drowsiness that can accompany motion sickness.
The effectiveness of Seibu tablets in mitigating motion sickness has been observed in clinical studies. The combined action of scopolamine hydrobromide hydrate, chlorpheniramine maleate, and anhydrous caffeine has shown promise in reducing the intensity and frequency of symptoms associated with motion-induced discomfort.
Seibu tablets are suitable for both adults and children aged 7 and older, broadening their application for individuals of varying ages who experience motion sickness. Additionally, Seibu tablets are reported to have relatively few contraindications and side effects.
Active principles: scopolamine hydrobromide hydrate, chlorpheniramine maleate, anhydrous caffeine
Amount: 8 tablets
Maker: Kobayashi Pharmaceutical Co., Ltd., Osaka, Japan
Indications: Seibu tablets are effective in treating symptoms of motion sickness, such as:
Take the medicine 30 minutes to 1 hour before you leave for motion sickness prevention.
Children 7-14 years old: take 1 tablet at a time.
Adults over 15 years old: take 2 tablets at a time.
Do not take more than 2 tablets per day. Wait at least 4 hours between the intakes.
Contraindications: do not use for pregnant or breastfeeding women. Do not use for children under 7 years old, elderly patients; patients with glaucoma, heart disease, or urinating difficulties.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.
